Hansa Biopharma Balance Sheet Health
Financial Health criteria checks 1/6
Hansa Biopharma has a total shareholder equity of SEK-167.9M and total debt of SEK844.9M, which brings its debt-to-equity ratio to -503.3%. Its total assets and total liabilities are SEK1.0B and SEK1.2B respectively.
Key information
-503.3%
Debt to equity ratio
kr844.90m
Debt
Interest coverage ratio | n/a |
Cash | kr732.06m |
Equity | -kr167.88m |
Total liabilities | kr1.19b |
Total assets | kr1.02b |
Recent financial health updates
Does Hansa Biopharma (STO:HNSA) Have A Healthy Balance Sheet?
Sep 22Rock star Growth Puts Hansa Biopharma (STO:HNSA) In A Position To Use Debt
Apr 03We're Keeping An Eye On Hansa Biopharma's (STO:HNSA) Cash Burn Rate
Mar 23Recent updates
Analyst Estimates: Here's What Brokers Think Of Hansa Biopharma AB (publ) (STO:HNSA) After Its Yearly Report
Feb 07Hansa Biopharma AB (publ) (STO:HNSA) Not Lagging Industry On Growth Or Pricing
Dec 28Newsflash: Hansa Biopharma AB (publ) (STO:HNSA) Analysts Have Been Trimming Their Revenue Forecasts
Oct 13Does Hansa Biopharma (STO:HNSA) Have A Healthy Balance Sheet?
Sep 22Investors Holding Back On Hansa Biopharma AB (publ) (STO:HNSA)
May 31Rock star Growth Puts Hansa Biopharma (STO:HNSA) In A Position To Use Debt
Apr 03Hansa Biopharma AB (publ) (STO:HNSA) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Feb 06Need To Know: The Consensus Just Cut Its Hansa Biopharma AB (publ) (STO:HNSA) Estimates For 2023
Feb 01We're Keeping An Eye On Hansa Biopharma's (STO:HNSA) Cash Burn Rate
Mar 23Financial Position Analysis
Short Term Liabilities: HNSA has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: HNSA has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: HNSA has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: HNSA's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: HNSA has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: HNSA has sufficient cash runway for 1.6 years if free cash flow continues to reduce at historical rates of 23% each year.